Table 2.
Receptor subtype | Source | 3H ligand | Mean % inhibition |
---|---|---|---|
5-HT1A | Human (H), cloned | 8-OH-DPAT | −2.5 |
5-HT1B | H, cloned | GR-125743 / 5CT | −5.4 |
5-HT1D | H, cloned | GR-125743 / 5CT | −5.9 |
5-HT1E | H, cloned | 5HT | −0.5 |
5-HT2A | H, cloned | Ketanserin | 0.9 |
5-HT2B | H, cloned | LSD | −14.5 |
5-HT2C | Rat, cloned | Mesulergine | 38.7 |
5-HT3 | H, cloned | LY 278,584 | 2.4 |
5-HT5A | H, cloned | LSD | −6.9 |
5-HT6 | H, cloned | LSD | −18.3 |
5-HT7 | H, cloned | LSD | 0.0 |
Alpha1A | H, cloned | Prazosin / 125I-heat | 27.8 |
Alpha1B | H, cloned | Prazosin / 125I-heat | 8.7 |
Alpha1D | H, cloned | 3H-Prazocin | 4.3 |
Alpha2A | H, cloned | Clonidine (2nM) / 125Iodoclonidine | 1.7 |
Alpha2B | H, cloned | Clonidine (2nM) / 125Iodoclonidine | 4.0 |
Alpha2C | H, cloned | Clonidine (2nM) / 125Iodoclonidine | 12.6 |
Beta1 | H, cloned | Dihydroalprenolol / 125Iodopindolol | −1.8 |
Beta2 | H, cloned | Dihydroalprenolol / 125Iodopindolol | −4.0 |
Beta3 | H, cloned | Dihydroalprenolol / 125Iodopindolol | −7.6 |
BZP Rat Brain Site | Rat brain | Flunitrazepam | −0.9 |
Calcium Channel | Rat heart | [3H]-Nitrendipine (0.1 nM) | Ki > 10,000 nM |
D1 | H, cloned | SCH23390 | |
D2 | H, cloned | N-Methylspiperone, NMSP | −5.9 |
D3 | H, cloned | N-Methylspiperone, NMSP | 6.4 |
D4 | H, cloned | N-Methylspiperone, NMSP | 63.4 |
D5 | H, cloned | SCH23390 | 12.9 |
DAT | H, cloned | WIN35428 | 5.9 |
DOR | H, cloned | DADL | 10.0 |
GABAA | Rat, forebrain | Muscimol | 39.5 |
H1 | H, cloned | Pyrilamine | 51.2 |
H2 | H, cloned | Tiotodine | 12.2 |
KOR | Rat, cloned | U69593 | 6.7 |
M1 | H, cloned | [3H]-QNB (0.5 nM) | −11.7 |
M2 | H, cloned | [3H]-QNB (0.5 nM) | 8.5 |
M3 | H, cloned | [3H]-QNB (0.5 nM) | 27.9 |
M4 | H, cloned | [3H]-QNB (0.5 nM) | 5.0 |
M5 | H, cloned | [3H]-QNB (0.5 nM) | −0.6 |
MOR | H, cloned | DAMGO | −10.3 |
NET | H, cloned | Nisoxetine | 11.7 |
SERT | H, cloned | Citalopram | 12.2 |
Sigma1 | GP rat brain | [3H]-Pentazocine (3 nM) | 26.6 |
Sigma2 | PC12 | [3H]-DTG (3 nM) | −14.7 |